St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
New combo therapy aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-stage trial tests whether adding a new drug called roginolisib to the existing treatment tebentafusp can help people with advanced uveal melanoma, a rare eye cancer. The study involves 8 adults whose cancer has spread and who are already on tebentafusp. The main goal i…
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
Hormone boost plus chemo aims to shrink hard-to-treat prostate cancer
Disease control Recruiting nowThis study tests whether a high dose of testosterone combined with the chemotherapy drug carboplatin can help men with a specific type of advanced prostate cancer that has stopped responding to standard hormone therapy. About 30 men with a genetic defect called homologous recombi…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Prostate cancer study asks men: what do you think about breast side effects?
Knowledge-focused Recruiting nowThis study interviews 24 men with prostate cancer to learn how they feel about breast-related side effects, such as gynecomastia (enlarged breasts), from treatment. The goal is to understand what matters most to patients when choosing therapies. Results will help design a future …
Phase: NA • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:55 UTC